Addressing Risks Associated with IV Push Medication Use in Adults

Experts will address the variability of practice with IV push medication use, including unnecessary unit-based preparation and dilution and unsafe injection practices, highlighting strategies necessary for the mitigation of risk.

Advancing Personalized Treatment of Patients with Hemophilia Through Comprehensive Pharmacokinetic Assessment

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Changing the Safety Paradigm on IV Medication Use: Recognizing the Risk and Taking Action

This activity will address the multi-factorial risks associated with IV medications, along with the need for proven safety technologies, practice innovation, and educational strategies to enhance safety in all phases of the medication use process.

Contemporary Practice Pearls for Pulmonary Arterial Hypertension

This activity will focus on individualized treatment strategies for PAH therapy. Faculty will cover insights into PAH pathophysiology, therapies and the most recent data surrounding their uses, and navigating clinical guidelines.

Creating Impact in the Treatment and Prevention of Recurrent C. Difficile Infection

This activity will address patient education and counseling reminders to reduce the risk of recurrence, patient-specific risk factors for recurrent CDI, recommended and emerging treatments for recurrent CDI, and factors in health-system reduction of rCDI.

Evaluating Practices in the Treatment of HABP/VABP

This activity will discuss the prevention and treatment of HABP/VABP for clinical and infectious diseases pharmacists. Special attention will be given to available and emerging treatment options, along with pertinent patient considerations and monitoring strategies.

Examining Strategies to Manage Antimicrobial Resistance Mechanisms

This activity will discuss mechanisms of resistance, management strategies for highlighted community and hospital-acquired infectious diseases with the most resistance-related concerns, and substitute therapeutic options when guideline or protocol-directed therapies are found to be ineffective.

Management and Trends in Pulmonary Arterial Hypertension

This activity will provide learners with foundational knowledge of PAH, including the role of several unique pathways.

MS-101: Pathogenesis, Diagnostic and Clinical Course Treatment Considerations in MS (A CSPE Core Curriculum Series)

This activity provides an introduction to MS pathology, epidemiology, and symptom management to specialty pharmacists and nurses.

MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series)

This activity provides an introduction to MS pathology, epidemiology, and symptom management to specialty pharmacists and nurses.